Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.52 |
| ▸ | NOS1 | P29475 | 1/20 | 0.52 |
| ▸ | NOS2 | P35228 | 1/20 | 0.52 |
| ▸ | BTK | Q06187 | 2/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.33 |
| ▸ | RIOK2 | Q9BVS4 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.32 |
| ▸ | LOX | P28300 | 2/20 | 0.32 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.31 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20920751 | 0.85 | BTK (0.36) | NOS3NOS1NOS2BTKHDAC8 | |
| SCHEMBL662664 | 0.82 | NOS3 (0.53) | NOS3NOS1NOS2KDM4EL3MBTL1 | |
| SCHEMBL24696617 | 0.80 | TDP1 (0.41) | L3MBTL1CYP3A4 | |
| SCHEMBL9899588 | 0.80 | RECQL (0.52) | NOS3NOS1NOS2BTKHDAC8 | |
| SCHEMBL20621291 | 0.80 | NOS3 (0.52) | NOS3NOS1NOS2KDM4EL3MBTL1 | |
| SCHEMBL6642166 | 0.80 | NOS3 (0.52) | NOS3NOS1NOS2KDM4EL3MBTL1 | |
| SCHEMBL19728333 | 0.79 | GABRA1 (0.37) | NOS3NOS1NOS2BTKHDAC8 | |
| SCHEMBL27295287 | 0.79 | NOS3 (0.35) | NOS3NOS1NOS2CYP1A2CYP2D6 | |
| SCHEMBL22007014 | 0.78 | NOS2 (0.50) | NOS3NOS1NOS2KDM4EL3MBTL1 | |
| SCHEMBL10815614 | 0.77 | KDM4E (0.38) | BTKHDAC8KDM4ERECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4172862-A | CONJUGATED DIOLEFIN, VINYL AROMATIC, VINYLPYRIDINE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1979-10-30 | — | — | US | claimed |
| US-12018002-B2 | Certain chemical entities, compositions, and methods | NEUPHARMA, INC (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240067656-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-02-29 | — | — | US | disclosed |
| US-11718630-B2 | Compositions and methods for treating cancer | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-08-08 | — | — | US | disclosed |
| US-20230135350-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-05-04 | — | — | US | disclosed |
| US-20230043970-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | NEUPHARMA, INC | 2023-02-09 | — | — | US | disclosed |
| US-11358940-B2 | K-Ras modulators | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-06-14 | — | — | US | disclosed |
| US-20210230183-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-07-29 | — | — | US | disclosed |
| US-10857140-B2 | K-Ras modulators | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-12-08 | — | — | US | disclosed |
| US-20200247762-A1 | K-RAS MODULATORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-08-06 | — | — | US | disclosed |
| US-4664822-A | OVERBASED COMPOUND CONTAINING COPPER | AMOCO CORPORATION (US) | 1987-05-12 | — | — | US | disclosed |
| EP-0089856-B1 | IMPROVED CONCENTRATES OF LUBRICANT ADDITIVES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-11-05 | — | — | EP | disclosed |
| EP-0167295-A2 | Improved lubricating compositions | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-01-08 | — | — | EP | disclosed |
| EP-0024146-B1 | IMPROVED LUBRICATING COMPOSITIONS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1985-10-09 | — | — | EP | disclosed |
| US-4502970-A | POLYISOBUTENYL SUCCINIC ANHYDRIDE | EXXON RESEARCH & ENGINEERING CO. (US) | 1985-03-05 | — | — | US | disclosed |
| US-4502971-A | REDUCED INCREASE IN VISCOSITY OF DISPERSANT AND BASIC MAGNESIUM DETERGENT | EXXON RESEARCH & ENGINEERING CO. (US) | 1985-03-05 | — | — | US | disclosed |
| EP-0096539-A2 | Lubricating oil composition | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-12-21 | — | — | EP | disclosed |
| EP-0089856-A2 | Improved concentrates of lubricant additives | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-09-28 | — | — | EP | disclosed |
| EP-0024146-A1 | Improved lubricating compositions | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1981-02-25 | — | — | EP | disclosed |
| US-4172862-A | CONJUGATED DIOLEFIN, VINYL AROMATIC, VINYLPYRIDINE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1979-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043970-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | BRAF, PIK3CA, PLK1 | NOS3 3512/4885NOS1 4194/4885NOS2 3733/4885 |
| US-20230135350-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | KRAS, HRAS, NRAS | NOS3 2205/4885NOS1 2835/4885NOS2 2483/4885 |
| US-12018002-B2 | Certain chemical entities, compositions, and methods | BRAF, PIK3CA, PLK1 | NOS3 3512/4885NOS1 4194/4885NOS2 3733/4885 |
| US-20200247762-A1 | K-RAS MODULATORS | KRAS, HRAS, NRAS | NOS3 4470/4885NOS1 4233/4885NOS2 4268/4885 |
| US-11718630-B2 | Compositions and methods for treating cancer | KRAS, HRAS, NRAS | NOS3 2205/4885NOS1 2835/4885NOS2 2483/4885 |
| US-20210230183-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | KRAS, HRAS, NRAS | NOS3 2205/4885NOS1 2835/4885NOS2 2483/4885 |
| US-11358940-B2 | K-Ras modulators | KRAS, HRAS, NRAS | NOS3 3703/4885NOS1 3580/4885NOS2 3532/4885 |
| US-10857140-B2 | K-Ras modulators | KRAS, HRAS, NRAS | NOS3 4270/4885NOS1 3690/4885NOS2 3786/4885 |
| US-20240067656-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | KRAS, HRAS, NRAS | NOS3 2205/4885NOS1 2835/4885NOS2 2483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.